Next Article in Journal
Exogenous Liposomal Ceramide-C6 Ameliorates Lipidomic Profile, Energy Homeostasis, and Anti-Oxidant Systems in NASH
Previous Article in Journal
Fractionation-Dependent Radiosensitization by Molecular Targeting of Nek1
Previous Article in Special Issue
Modulation of mTORC1 Signaling Pathway by HIV-1
Open AccessReview

Understanding Glioblastoma Biomarkers: Knocking a Mountain with a Hammer

Department of Biochemistry, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, UPM Serdang 43400, Selangor, Malaysia
*
Author to whom correspondence should be addressed.
Cells 2020, 9(5), 1236; https://doi.org/10.3390/cells9051236
Received: 17 February 2020 / Revised: 18 March 2020 / Accepted: 24 March 2020 / Published: 16 May 2020
(This article belongs to the Collection Compartmentilisation of Cellular Signaling)
Gliomas are the most frequent and deadly form of human primary brain tumors. Among them, the most common and aggressive type is the high-grade glioblastoma multiforme (GBM), which rapidly grows and renders patients a very poor prognosis. Meanwhile, cancer stem cells (CSCs) have been determined in gliomas and play vital roles in driving tumor growth due to their competency in self-renewal and proliferation. Studies of gliomas have recognized CSCs via specific markers. This review comprehensively examines the current knowledge of the most significant CSCs markers in gliomas in general and in glioblastoma in particular and specifically focuses on their outlook and importance in gliomas CSCs research. We suggest that CSCs should be the superior therapeutic approach by directly targeting the markers. In addition, we highlight the association of these markers with each other in relation to their cascading pathways, and interactions with functional miRNAs, providing the role of the networks axes in glioblastoma signaling pathways. View Full-Text
Keywords: gliomas; glioblastoma; cancer stem cells; CSCs markers; miRNAs gliomas; glioblastoma; cancer stem cells; CSCs markers; miRNAs
Show Figures

Figure 1

MDPI and ACS Style

Hassn Mesrati, M.; Behrooz, A.B.; Y. Abuhamad, A.; Syahir, A. Understanding Glioblastoma Biomarkers: Knocking a Mountain with a Hammer. Cells 2020, 9, 1236.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop